Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
暂无分享，去创建一个
P. Debré | C. Dutertre | F. Davi | E. Chapiro | H. Merle-Béral | J. Prost | J. Teillaud | V. Vieillard | C. Parizot | C. Romeuf | M. Garff-Tavernier | J. Decocq | Vincent Vieillard | Julie Decocq | Patrice Debré | Frédéric Davi | Jean-François Prost | J. L. Teillaud